##gff-version 3
##sequence-region Q12948 1 553
Q12948	UniProtKB	Chain	1	553	.	.	.	ID=PRO_0000091806;Note=Forkhead box protein C1	
Q12948	UniProtKB	DNA binding	77	168	.	.	.	Note=Fork-head;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00089	
Q12948	UniProtKB	Region	1	51	.	.	.	Note=Required for transcriptional activation;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11782474;Dbxref=PMID:11782474	
Q12948	UniProtKB	Region	215	366	.	.	.	Note=Required for transcriptional inhibition;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11782474;Dbxref=PMID:11782474	
Q12948	UniProtKB	Region	466	553	.	.	.	Note=Required for transcriptional activation;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11782474;Dbxref=PMID:11782474	
Q12948	UniProtKB	Motif	78	93	.	.	.	Note=Nuclear localization signal 1 (NLS 1);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11782474;Dbxref=PMID:11782474	
Q12948	UniProtKB	Motif	168	176	.	.	.	Note=Nuclear localization signal 2 (NLS 2);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11782474;Dbxref=PMID:11782474	
Q12948	UniProtKB	Compositional bias	28	33	.	.	.	Note=Poly-Ala	
Q12948	UniProtKB	Compositional bias	169	173	.	.	.	Note=Poly-Arg	
Q12948	UniProtKB	Compositional bias	194	197	.	.	.	Note=Poly-Pro	
Q12948	UniProtKB	Compositional bias	262	272	.	.	.	Note=Poly-Ser	
Q12948	UniProtKB	Compositional bias	292	297	.	.	.	Note=Poly-Pro	
Q12948	UniProtKB	Compositional bias	375	382	.	.	.	Note=Poly-Gly	
Q12948	UniProtKB	Compositional bias	438	445	.	.	.	Note=Poly-Ser	
Q12948	UniProtKB	Compositional bias	447	456	.	.	.	Note=Poly-Gly	
Q12948	UniProtKB	Compositional bias	486	495	.	.	.	Note=Poly-Ala	
Q12948	UniProtKB	Modified residue	235	235	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:18691976;Dbxref=PMID:18669648,PMID:18691976	
Q12948	UniProtKB	Modified residue	241	241	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18691976;Dbxref=PMID:18691976	
Q12948	UniProtKB	Modified residue	272	272	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16492674;Dbxref=PMID:16492674	
Q12948	UniProtKB	Modified residue	320	320	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18691976,PMID:20068231,PMID:23186163	
Q12948	UniProtKB	Modified residue	521	521	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q12948	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_058722;Note=In RIEG3%3B decreased location at the nucleus%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity%3B no change on DNA bending activity. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11170889,ECO:0000269|PubMed:14506133;Dbxref=PMID:11170889,PMID:14506133	
Q12948	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_058723;Note=In RIEG3. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16936096;Dbxref=PMID:16936096	
Q12948	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_058724;Note=In RIEG3%3B decreased location at the nucleus%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity%3B no change on DNA bending activity. P->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11589884,ECO:0000269|PubMed:14506133;Dbxref=PMID:11589884,PMID:14506133	
Q12948	UniProtKB	Natural variant	82	82	.	.	.	ID=VAR_007944;Note=In RIEG3%3B decreased location at the nucleus%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity. S->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11179011,ECO:0000269|PubMed:14506133,ECO:0000269|PubMed:9792859;Dbxref=dbSNP:rs104893953,PMID:11179011,PMID:14506133,PMID:9792859	
Q12948	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_078501;Note=In RIEG3%3B unknown pathological significance. A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17653043;Dbxref=PMID:17653043	
Q12948	UniProtKB	Natural variant	86	86	.	.	.	ID=VAR_058725;Note=In RIEG3%3B no change in location at the nucleus%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14578375;Dbxref=dbSNP:rs886039568,PMID:14578375	
Q12948	UniProtKB	Natural variant	87	87	.	.	.	ID=VAR_007945;Note=In RIEG3%3B loss of protein stability. I->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11179011,ECO:0000269|PubMed:9792859;Dbxref=dbSNP:rs104893954,PMID:11179011,PMID:9792859	
Q12948	UniProtKB	Natural variant	91	91	.	.	.	ID=VAR_058726;Note=In RIEG3%3B decreased location at the nucleus%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity%3B no change on DNA bending activity. I->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11740218,ECO:0000269|PubMed:14506133;Dbxref=PMID:11740218,PMID:14506133	
Q12948	UniProtKB	Natural variant	91	91	.	.	.	ID=VAR_058727;Note=In RIEG3%3B decreased location at the nucleus%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity%3B no change on DNA bending activity. I->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14506133,ECO:0000269|PubMed:15477465;Dbxref=PMID:14506133,PMID:15477465	
Q12948	UniProtKB	Natural variant	109	109	.	.	.	ID=VAR_078502;Note=In ASGD3. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20881294;Dbxref=dbSNP:rs917382067,PMID:20881294	
Q12948	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_007815;Note=In ASGD3 and RIEG3%3B decreased location at the nucleus%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity. F->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11179011,ECO:0000269|PubMed:12614756,ECO:0000269|PubMed:14506133,ECO:0000269|PubMed:9620769;Dbxref=dbSNP:rs104893951,PMID:11179011,PMID:12614756,PMID:14506133,PMID:9620769	
Q12948	UniProtKB	Natural variant	115	115	.	.	.	ID=VAR_058728;Note=In RIEG3. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16936096;Dbxref=PMID:16936096	
Q12948	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_007816;Note=In ASGD3 and RIEG3%3B with glaucoma%3B decreased location at the nucleus%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity. I->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11179011,ECO:0000269|PubMed:14506133,ECO:0000269|PubMed:9620769;Dbxref=dbSNP:rs104893958,PMID:11179011,PMID:14506133,PMID:9620769	
Q12948	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_078503;Note=In RIEG3%3B hypomorphic mutation%3B decreased protein abundance%3B decreased protein stability%3B changed post-translational phosphorylation%3B decreased location at the nucleus%3B novel location at the cytoplasm%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity. I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25786029;Dbxref=dbSNP:rs483352810,PMID:25786029	
Q12948	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_058729;Note=In RIEG3%3B decreased location at the nucleus%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11740218,ECO:0000269|PubMed:14506133,ECO:0000269|PubMed:16449236;Dbxref=PMID:11740218,PMID:14506133,PMID:16449236	
Q12948	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_078504;Note=In RIEG3. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24914578;Dbxref=dbSNP:rs1085307884,PMID:24914578	
Q12948	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_078505;Note=In RIEG3%3B no effect on protein abundance%3B increased protein stability%3B decreased location at nucleus%3B loss of transcription regulatory region DNA binding%3B loss of sequence-specific DNA binding transcription factor activity. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27804176;Dbxref=PMID:27804176	
Q12948	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_058730;Note=In RIEG3%3B no effect on protein abundance%3B changed post-translational phosphorylation%3B novel location at aggresome%2C aggregation correspond to microtubule-dependent inclusion bodies%3B decreased location at the nucleus%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity. L->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17210863,ECO:0000269|PubMed:19279310;Dbxref=dbSNP:rs121909338,PMID:17210863,PMID:19279310	
Q12948	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_007817;Note=In RIEG3 and ASGD3%3B with glaucoma%3B decreased location at the nucleus%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity. S->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11170889,ECO:0000269|PubMed:11179011,ECO:0000269|PubMed:14506133,ECO:0000269|PubMed:16449236,ECO:0000269|PubMed:9620769;Dbxref=dbSNP:rs104893957,PMID:11170889,PMID:11179011,PMID:14506133,PMID:16449236,PMID:9620769	
Q12948	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_078506;Note=In ASGD3. S->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20881294;Dbxref=PMID:20881294	
Q12948	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_078507;Note=In RIEG3%3B decreased protein abundance%3B decreased protein stability%3B decreased location at nucleus%3B loss of transcription regulatory region DNA binding%3B loss of sequence-specific DNA binding transcription factor activity. C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27804176;Dbxref=PMID:27804176	
Q12948	UniProtKB	Natural variant	138	138	.	.	.	ID=VAR_078508;Note=In ASGD3. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20881294;Dbxref=PMID:20881294	
Q12948	UniProtKB	Natural variant	149	149	.	.	.	ID=VAR_058731;Note=In RIEG3. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16936096;Dbxref=PMID:16936096	
Q12948	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_078509;Note=In ASGD3%3B no change in protein abundance%3B changed post-translational phosphorylation%3B changed protein structure%3B decreased location at the nucleus%3B novel location at the cytoplasm%3B increased protein aggregation%2C aggregation do not correspond to microtubule-dependent inclusion bodies%3B loss of transcription regulatory region DNA binding%3B loss of sequence-specific DNA binding transcription factor activity. W->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19279310;Dbxref=PMID:19279310	
Q12948	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_018150;Note=In RIEG3 and ASGD3%3B no change in location at the nucleus%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity. M->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12454026,ECO:0000269|PubMed:12592227,ECO:0000269|PubMed:15277473,ECO:0000269|PubMed:18484311;Dbxref=PMID:12454026,PMID:12592227,PMID:15277473,PMID:18484311	
Q12948	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_058732;Note=In RIEG3%3B no effect on protein abundance%3B no effect on protein stability%3B no effect on location at nucleus%3B no effect on transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity. M->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16936096,ECO:0000269|PubMed:27804176;Dbxref=PMID:16936096,PMID:27804176	
Q12948	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_058733;Note=In RIEG3%3B no change in location at the nucleus%3B no effect on transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15277473;Dbxref=PMID:15277473	
Q12948	UniProtKB	Natural variant	169	169	.	.	.	ID=VAR_058734;Note=In RIEG3%3B no change in location at the nucleus%3B decreased transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15277473;Dbxref=PMID:15277473	
Q12948	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_078510;Note=In RIEG3%3B unknown pathological significance. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23239455;Dbxref=PMID:23239455	
Q12948	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_078511;Note=In ASGD3%3B no effect on protein abundance%3B increased protein stability%3B no effect on nuclear location%3B no effect on transcription regulatory region DNA binding%3B decreased sequence-specific DNA binding transcription factor activity. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19793056;Dbxref=dbSNP:rs79691946,PMID:19793056	
Q12948	UniProtKB	Natural variant	368	368	.	.	.	ID=VAR_078512;Note=No effect on protein abundance%3B no effect on protein stability%3B no effect on nuclear location%3B no effect on transcription regulatory region DNA binding%3B no effect on sequence-specific DNA binding transcription factor activity. T->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27804176;Dbxref=PMID:27804176	
Q12948	UniProtKB	Mutagenesis	68	68	.	.	.	Note=No effect on protein stability. No effect on transcriptional activity. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16492674;Dbxref=PMID:16492674	
Q12948	UniProtKB	Mutagenesis	79	79	.	.	.	Note=Decreased nuclear localization. No effect on DNA-binding activity. Decreased transcriptional activity. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	79	79	.	.	.	Note=Decreased nuclear localization. No effect on DNA-binding activity. Decreased transcriptional activity. P->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	79	79	.	.	.	Note=Decreased nuclear localization. No effect on DNA-binding activity. Decreased transcriptional activity. P->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	86	86	.	.	.	Note=Decreased nuclear localization. No effect on DNA-binding activity. Decreased transcriptional activity. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	86	86	.	.	.	Note=Decreased nuclear localization. No effect on DNA-binding activity. Decreased transcriptional activity. L->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	86	86	.	.	.	Note=Decreased nuclear localization. No effect on DNA-binding activity. Decreased transcriptional activity. L->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	86	86	.	.	.	Note=Severely disrupts the protein function. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14578375;Dbxref=PMID:14578375	
Q12948	UniProtKB	Mutagenesis	87	87	.	.	.	Note=Loss of protein stability. I->A%2CE%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Decreased nuclear localization. Decreased DNA-binding activity. Decreased transcriptional activity. I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Decreased nuclear localization. No effect on DNA-binding activity. Decreased transcriptional activity. I->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Decreased nuclear localization. No effect on DNA-binding activity. Decreased transcriptional activity. I->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Decreased nuclear localization. Decreased DNA-binding activity. Decreased transcriptional activity. I->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Decreased nuclear localization. Decreased DNA-binding activity. Decreased transcriptional activity. I->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Decreased nuclear localization. Decreased DNA-binding activity. Decreased transcriptional activity. I->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	127	127	.	.	.	Note=Decreased nuclear localization. Decreased DNA-binding activity. Decreased transcriptional activity. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	127	127	.	.	.	Note=Decreased nuclear localization. Decreased DNA-binding activity. Decreased transcriptional activity. R->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	127	127	.	.	.	Note=Decreased nuclear localization. Decreased DNA-binding activity. Decreased transcriptional activity. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15299087;Dbxref=PMID:15299087	
Q12948	UniProtKB	Mutagenesis	241	241	.	.	.	Note=Decreased protein stability. No effect on transcriptional activity. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16492674;Dbxref=PMID:16492674	
Q12948	UniProtKB	Mutagenesis	259	259	.	.	.	Note=No effect on protein stability. No effect on transcriptional activity. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16492674;Dbxref=PMID:16492674	
Q12948	UniProtKB	Mutagenesis	272	272	.	.	.	Note=Decreased protein stability. Decreased transcriptional activity. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16492674;Dbxref=PMID:16492674	
Q12948	UniProtKB	Sequence conflict	70	77	.	.	.	Note=QPQPKDMV->RSRSPRHG;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q12948	UniProtKB	Sequence conflict	101	101	.	.	.	Note=L->Q;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q12948	UniProtKB	Sequence conflict	180	180	.	.	.	Note=V->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q12948	UniProtKB	Sequence conflict	199	202	.	.	.	Note=RQPP->ASPR;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q12948	UniProtKB	Sequence conflict	426	426	.	.	.	Note=D->N;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q12948	UniProtKB	Sequence conflict	426	426	.	.	.	Note=D->N;Ontology_term=ECO:0000305;evidence=ECO:0000305	
